Promising New Therapy for Sarcomas Could Reduce Reliance on Surgery, Chemotherapy and other Invasive and Toxic Treatments CLEVELAND , March 12, 2024 /PRNewswire/ -- Lamassu Bio Inc., a cutting-edge biotech company dedicated to ...
PLEASANTON, Calif. , March 11, 2024 /PRNewswire/ -- DiaCarta, a leading molecular diagnostics company specializing in personalized patient care through liquid biopsy, proudly announced that Florida Health Department selected "using plasma ...
The Canadian venture capital fund CTI Life Sciences Fund III, Inveready and the EIC Fund from the European Commission close a round with the additional participation of CDTI Innvierte, FiTalent, family offices as well as founders. ...
YANTAI, China , March 10, 2024 /PRNewswire/ -- RemeGen Co. Ltd. ("RemeGen" or "the Company") (9995.HK, 688331.SH), a commercial-stage biotechnology company, recently gave an oral presentation on an interim analysis of the evaluation of ...
Board-certified dermatologist discusses occupational risks of skin cancer for those who serve SAN DIEGO , March 8, 2024 /PRNewswire/ -- U.S. veterans are at a higher risk of developing melanoma, one of the deadliest forms of skin ...
NANJING , China and GAITHURSBURG, Md. , March 8, 2024 /PRNewswire/ -- TransThera, a clinical-stage biopharmaceutical company dedicated to innovating differentiated drugs globally, today announced that the randomized, controlled, global ...
The University of Texas Health Science Center at San Antonio uses funding from the Cancer Prevention and Research Institute of Texas to attract top researchers and advance child and adolescent cancer research. SAN ANTONIO , March 7, ...
Autotaxin inhibitor, IOA-289, recently received the proposed INN cambritaxestat Cambritaxestat is in the Phase I AION-02 trial in combination with chemotherapy in metastatic pancreatic cancer It is the first autotaxin inhibitor to be ...
SOMERSET, N.J. , March 6, 2024 /PRNewswire/ -- Walter Krysevig, a 77-year-old cancer survivor from Somers, NY , embodies the transformative power of patient empowerment in navigating complex medical decisions. His proactive approach not ...
--CUSP06 is a CDH6-directed Antibody-Drug Conjugate (ADC) with a differentiated profile and potentially best-in-class activity-- NEW YORK , March 6, 2024 /PRNewswire/ -- OnCusp Therapeutics, Inc., a clinical stage biopharmaceutical ...
Researchers have discovered that the circadian clock, responsible for regulating daily physiological rhythms, including immune functions, can be utilized to improve the effectiveness of checkpoint inhibitor cancer therapy. These inhibitors prevent ...
Chronic myeloid leukemia (CML), a rare but treatable type of blood cancer , is significantly increasing among young adults aged 30 to 40 in India. CML ( ) affects the bone marrow and is characterized by the uncontrolled growth of white blood ...
Recent research has demonstrated the effectiveness of a novel therapy in reducing the size of challenging prostate and bladder cancers in mice. This therapy involves reprogramming immune cells to enhance their antitumor activity ...
New research indicates that bouts of moderate-to-vigorous intensity exercise could enhance the effectiveness of antibody therapies for treating chronic lymphocytic leukemia ( ). Researchers at the Universities of Birmingham and Bath discovered that a ...
Contrary to previous beliefs, genetics and family history outweigh sun exposure in determining the risk of melanoma, as per a new study from Cleveland Clinic in the US, published in the Journal of the American Academy of Dermatology ...
Subscribe to our Free Newsletters!
Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment.
Full Disclaimer
Advertise with us | Medindia Copyright | Privacy Policy | Terms of Use © All Rights Reserved 1997 - 2024
Careers